responses were observed in 11/27 hodgkin 's diseases , 10/30 lymphomas , 9/22 squamous cell cancers of ectodermal origin , 12/26 germinal cancers , and 3/8 renal adenocarcinomas .
C0006826
cancers
C0007134
renal adenocarcinomas